{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:57:28Z","timestamp":1787237848598,"version":"build-2736575974"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The Peyronie's Disease Questionnaire (PDQ) is a disease-specific, patient-reported outcome instrument designed to measure the psychosexual consequences and treatment outcomes of Peyronie's disease (PD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the test\u2013retest reliability of the PDQ.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult men with PD were recruited through eight clinical sites across the United States. Participants completed the PDQ during two study visits scheduled 7 (\u00b13) days apart. At Visit 1, participants completed a sociodemographic questionnaire, the PDQ, and the International Index of Erectile Function (IIEF). At Visit 2, participants repeated the PDQ and completed an Overall Treatment Effect (OTE) scale. Test\u2013retest reliability of the PDQ was assessed in a stable subsample (as determined by responses to the OTE). Intraclass correlation coefficients (ICCs) were calculated to evaluate the degree of association between the three PDQ subscale scores at Visits 1 and 2. Internal consistency of the subscales was also evaluated using Cronbach's alpha.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measure<\/jats:title>\n                    <jats:p>The main outcome measure was the PDQ.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 61 PD patients (mean age 59.3) who took part in the study, the majority were not receiving treatment for their PD (n = 35, 57.4%). The sample's mean score on the erectile function domain of IIEF was 19.7 (\u00b18.2), indicating mild\u2013moderate dysfunction. Nearly two-thirds reported penile pain at baseline (n = 37, 63.8%). Of the participants with baseline PDQ data and who had engaged in vaginal intercourse in the past 3 months, 57 completed both study visits. The PDQ demonstrated excellent test\u2013retest reliability in 53 stable patients. The ICC was 0.85 for the Psychological and Physical Symptom subscale, 0.89 for the Peyronie's Symptom Bother subscale, and 0.88 for the Penile Pain subscale. The Cronbach's alpha estimates for all three subscales were acceptable at the &amp;gt;0.70 level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The PDQ is a highly reproducible measure of PD and can be an effective end point in clinical trials evaluating treatments for PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jsm.12769","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T04:42:37Z","timestamp":1416199357000},"page":"543-548","source":"Crossref","is-referenced-by-count":22,"title":["The Test\u2013Retest Reliability of the Peyronie's Disease Questionnaire"],"prefix":"10.1093","volume":"12","author":[{"given":"Karin S.","family":"Coyne","sequence":"first","affiliation":[{"name":"Outcomes Research , Bethesda, MD , USA"},{"name":"Evidera , Bethesda, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke M.","family":"Currie","sequence":"additional","affiliation":[{"name":"Outcomes Research , Bethesda, MD , USA"},{"name":"Evidera , Bethesda, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Outcomes Research , Bethesda, MD , USA"},{"name":"Evidera , Bethesda, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Smith","sequence":"additional","affiliation":[{"name":"Biometrics , Chesterbrook, PA , USA"},{"name":"Auxilium Pharmaceuticals, Inc. , Chesterbrook, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,1]]},"reference":[{"key":"2023012309015540700_bb0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00042307-200309000-00010","article-title":"Peyronie's disease: A review","volume":"13","author":"Briganti","year":"2003","journal-title":"Curr Opin Urol"},{"key":"2023012309015540700_bb0015","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","article-title":"The natural history of Peyronie's disease","volume":"144","author":"Gelbard","year":"1990","journal-title":"J Urol"},{"key":"2023012309015540700_bb0020","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/jsm.12312","article-title":"Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease","volume":"10","author":"Gelbard","year":"2013","journal-title":"J Sex Med"},{"key":"2023012309015540700_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jsm.12337","article-title":"Concordance between patient and physician assessment of the magnitude of Peyronie's disease curvature","volume":"11","author":"Matsushita","year":"2014","journal-title":"J Sex Med"},{"key":"2023012309015540700_bb0030","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","article-title":"Bother and distress associated with Peyronie's disease: Validation of the Peyronie's disease questionnaire","volume":"190","author":"Hellstrom","year":"2013","journal-title":"J Urol"},{"key":"2023012309015540700_bb0035","first-page":"65132","article-title":"Guidance for industry on patient-reported outcome measures: Use in medical product development to support labeling claims","volume":"74","author":"US Food and Drug Administration (FDA)","year":"2009","journal-title":"Fed Regist"},{"key":"2023012309015540700_bb0040","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1023\/A:1008996223999","article-title":"Recommendations on health-related quality of life research to support labeling and promotional claims in the United States","volume":"9","author":"Revicki","year":"2000","journal-title":"Qual Life Res"},{"key":"2023012309015540700_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1524-4733.1999.02210.x","article-title":"Recommendations for evaluating the validity of quality of life claims for labeling and promotion","volume":"2","author":"Leidy","year":"1999","journal-title":"Value Health"},{"key":"2023012309015540700_bb0050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","article-title":"Measuring health-related quality of life","volume":"118","author":"Guyatt","year":"1993","journal-title":"Ann Intern Med"},{"key":"2023012309015540700_bb0055","article-title":"Responsiveness of the Peyronie's Disease Questionnaire (PDQ)","author":"Coyne","journal-title":"J Sex Med"},{"key":"2023012309015540700_bb0060","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"2023012309015540700_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","article-title":"Determining a minimal important change in a disease-specific Quality of Life Questionnaire","volume":"47","author":"Juniper","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"2023012309015540700_bb0070","article-title":"Psychometric theory","author":"Nunnally","year":"1994"},{"key":"2023012309015540700_bb0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of test","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"2023012309015540700_bb0080","article-title":"SAS\/GRAPH \u00ae 9.2 reference","year":"2010"},{"key":"2023012309015540700_bb0085","doi-asserted-by":"crossref","first-page":"e73990","DOI":"10.1371\/journal.pone.0073990","article-title":"The case for using the repeatability coefficient when calculating test\u2013retest reliability","volume":"8","author":"Vaz","year":"2013","journal-title":"PLoS ONE"},{"key":"2023012309015540700_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006199-200201000-00009","article-title":"Examining test-retest reliability: An intra-class correlation approach","volume":"51","author":"Yen","year":"2002","journal-title":"Nurs Res"},{"key":"2023012309015540700_bb0095","article-title":"Assessing reliability and validity of measurement in clinical trials","author":"Hays","year":"1998"},{"key":"2023012309015540700_bb0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","article-title":"Intraclass correlations: Uses in assessing rater reliability","volume":"86","author":"Shrout","year":"1979","journal-title":"Psychol Bull"},{"key":"2023012309015540700_bb0105","article-title":"Statistics in kinesiology","author":"Vincent","year":"1999"},{"key":"2023012309015540700_bb0110","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0895-4356(03)00084-2","article-title":"A comparison of two time intervals for test-retest reliability of health status instruments","volume":"56","author":"Marx","year":"2003","journal-title":"J Clin Epidemiol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515309322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515309322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/2\/543\/48625055\/jsm_12_2_543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/2\/543\/48625055\/jsm_12_2_543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T04:23:21Z","timestamp":1674447801000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/12\/2\/543\/6980160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,1]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12769","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,2]]},"published":{"date-parts":[[2015,2,1]]}}}